therapy. Meropenem, a parenteral carbapenem, has excellent activity against all Gram-negative and Gram-positive anaerobic … pathogens, and slightly more variable activity against Gram-positive aerobic organisms. In 8 clinical trials, meropenem 3 g … used in the empirical treatment of neutropenic patients with febrile episodes. Response rates with meropenem at treatment …

Meropenem is a carbapenem antibiotic which is active against the majority of aerobic and anaerobic bacteria implicated …/cilastatin and standard combination drug regimens. Hence, meropenem is suitable for use as monotherapy. Although the acquisition cost … of meropenem is likely to be higher than that of aminoglycoside- and metronidazole-containing combination regimens, the …